Predicted Trait | |
Reported Trait | Pancreatic cancer |
Mapped Trait(s) | pancreatic carcinoma (EFO_0002618) |
Score Construction | |
PGS Name | CC_Pancreas_IV |
Development Method | |
Name | 22 variants from Graff et al (PGS000083) with inverse variant weights |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 22 |
Effect Weight Type | Inverse-variance weighting |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000186 |
Citation (link to publication) | Kachuri L et al. Nat Commun (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST002991 Europe PMC: 26098869 |
636 individuals | NR, Hispanic or Latin American, African unspecified, Asian unspecified | 9 cohorts
|
GWAS Catalog: GCST005434 Europe PMC: 29422604 |
21,536 individuals | European | PANSCAN |
GWAS Catalog: GCST002553 Europe PMC: 25086665 |
6,785 individuals | European | 16 cohorts
|
GWAS Catalog: GCST003758 Europe PMC: 27579533 |
13,952 individuals | European | 28 cohorts
|
GWAS Catalog: GCST002991 Europe PMC: 26098869 |
7,046 individuals | NR | 9 cohorts
|
GWAS Catalog: GCST002991 Europe PMC: 26098869 |
7,320 individuals | European | 9 cohorts
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002065 | PSS001022| European Ancestry| 391,491 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident pancreatic cancer | HR: 1.49 [1.37, 1.63] | AUROC: 0.745 C-index: 0.743 (0.012) |
R²: 0.439 | Age at assessment, sex, genotyping array, PCs(1-15), family history of cancer (prostate, breast, lung, bowel), body mass index, cigarette pack-years, smoking status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001022 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |